SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Xavier who wrote (124)4/8/1998 5:45:00 PM
From: Jim Mac  Read Replies (1) of 413
 
LCAV jumped over 40% today on procedure growth news. Now, since LVCI has 1/4 the shares outstanding, more efficient laser utilization, current profitability (April should be profitable, and July Q looks like $0.10 non-taxed, while calendar 1999 looks like $1.00 fully-taxed, especially thanks to hyperopia), faces less competition, has more flexibility with its mobiles, and has less fixed overhead, doesn't it seem reasonable that LVCI should be at $14 or $15 now?

Or will the LT advantage go to the operator with the most urban fixed sites?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News